COVID-19

Adriana Hung, MD, MPH, talks with patient Sylvester Norman, who is participating in the VA Department’s Million Veteran Program.
February 10, 2022

Gene variants increase risk of kidney failure in veterans of African ancestry with COVID-19: study

Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19.

By Leigh MacMillan
Cody Stubblefield, RN, gives the first of two injections of an antibody combination to Caroline Davis to protect her from COVID-19.
February 9, 2022

Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization

Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.

By Kristin Smart
February 7, 2022

Study shows life-saving benefit of baricitinib for ventilated COVID patients

Vanderbilt research shows that critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib.

By Craig Boerner
February 4, 2022

A memoir of the COVID years: a Vanderbilt ICU nurse remembers patients who died, families who wept, and discovers the importance of hearing “thank you” and caring for herself

“I realized that my mechanism of avoiding and ignoring death in the workplace had taken its toll on me.”

By Rebecca Tucci
The virtual Advanced Practice Grand Rounds focused on the experience of caring for COVID-19 patients for nearly two years.
February 3, 2022

Advanced Practice Grand Rounds explores COVID’s impact

The recent VUMC Advanced Practice Grand Rounds explored the impact the ongoing COVID-19 pandemic is having on the nursing workforce.

By Matt Batcheldor
January 24, 2022

Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines

Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.

By Jessica Pasley
January 20, 2022

Omicron evades some but not all monoclonal antibodies: study

A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States.
By Bill Snyder
January 6, 2022

Grant boosts vaccine effectiveness research

By Nancy Humphrey
December 28, 2021

Chad Fitzgerald experienced the pandemic from unique vantage point

"His steady voice and hand has modulated the emotional ups and downs each of us has experienced."
By Jill Clendening
December 24, 2021

Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate

New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death.
By Tom Wilemon
December 23, 2021

The most popular VUMC Voice stories of 2021

Love stories, an honor walk, a heroic rescue -- and plumbing
By Wayne Wood
December 23, 2021

Patient receives antibodies discovered at Vanderbilt to prevent COVID-19 illness

On Dec. 22, Caroline Davis of Nashville became the first patient at Vanderbilt University Medical Center to receive injections of a new antibody combination to protect her from COVID-19.
By Bill Snyder
December 10, 2021

“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19

Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.
By Bill Snyder
1 … 6 7 8 9 10 … 40